UNSPSC 41202060: Sporothrix schenckiiserological reagents

In this classification, Sporothrix schenckii serological reagents are devices used in test to identify specific Sporothrix schenckii antibodies in serum. US FDA regulates Sporothrix schenckii serological reagents under 21 CFR 866.3680 and under FDA product code GMA.

UNSPSC 41202060 Sporothrix schenckii serological reagents is a Commodity code, but recent state and local procurement activity under this code shows minimal alignment with its nominal scope. The handful of opportunities posted since February 2026 involve HIV, Syphilis, and Hepatitis testing reagents and related diagnostic services—not Sporothrix schenckii serology specifically. State and local issuing bodies include county community supervision departments, municipal public health agencies, state health laboratories, university student health centers, and criminal justice agencies. The scope of work spans rapid point-of-care HIV test kits, fourth-generation combination screening assays for HIV/Hepatitis/Syphilis, automated laboratory instrumentation and reagents, forensic serology analysis (urine and feces stains with DNA testing), offender drug and specimen testing, and associated expert witness testimony for criminal proceedings. Most opportunities are posted by Texas and Illinois agencies, with activity also in Florida and scattered municipal procurement.

Representative recent solicitations include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000 over two years plus three optional renewals, covering two collection sites in Plano and McKinney with approximately 25,031 annual tests); the City of Austin's IFB for rapid HIV Type 1/2 test kits (due July 17, 2026, Abbott Determine kits at estimated 375 units annually); the Illinois Department of Public Health's IFB for a five-year Hepatitis/HIV/Syphilis fourth-generation assay contract with automated instrumentation (due March 16, 2026, approximately 3,300 Hepatitis B tests, 13,200 HIV tests, and 11,000 Syphilis tests annually); and the Texas Department of Criminal Justice's RFP for forensic analysis services including serology and DNA testing for inmate evidence (due May 13, 2026, with evaluation criteria of 40% cost, 35% technical capability, 15% past performance). The code shows activity skewed toward infectious disease serology broadly rather than the specific pathogen named in the code's taxonomy.